FDA Inspection
Takeda Pharamaceutical Company LimitedTakeda Pharamaceutical Company Limited – FDA Inspection, Jun 6, 2025
Record Details
This FDA Inspection record concerns Takeda Pharamaceutical Company Limited, with an inspection on June 6, 2025, issued by the Denver District Office, covering biologics.
View Company Profile
ID · d7a387ed-5276-41d8-894f-77bea6156cd4
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1274303
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 606.60(a)Equipment observed, standardized, calibrated
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Takeda Pharamaceutical Company Limited
2| Date | Classification | Office | Project area |
|---|---|---|---|
| July 17, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 10, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Takeda Pharamaceutical Company Limited
- FDA Inspection 1099094 - 2019-07-17
- FDA Inspection 1050331 - 2018-04-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.